fda warning compounded tirzepatide safety May 18, 2026: warns 503B compounding pharmacy for producing after shortage ended – Partnership for Safe Medicines Beware of Compounded Tirzepatide

However, these drugs are currently only FDA-approved for weight loss and diabetes, not addiction treatment

And because drugmakers have said they don't sell the active ingredients in their weight-loss shots to compounding pharmacies, it's unclear if the pharmacies are sourcing them from regulated suppliers

This means the medications mimic the effects of Glucagon-like peptide-1, or GLP-1

They demand lifelong adherence, and stopping them often leads to full weight regain

GHK-Cu Sequence: Gly-His-Lys-Cu Complex BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula: Variable Molecular Weight: Variable PubChem CID: GHK-Cu (CID 440217)